Skip to main content

Table 1 Patient demographics and baseline characteristics

From: Treat-and-extend therapy using intravitreal aflibercept for neovascular age-related macular degeneration: 2-year real-world practice data from Slovenia

 

Group A

Group B

p-value

Number of patients

105

33

 

Number of eyes

115

33

 

Female/Male

67/38

20/13

0.8367a

Age (years, mean ± SD)

77.3 ± 7.3

76.3 ± 8.4

0.5303b

VA (by eye, mean ± SD)

57.9 ± 14.9

62.4 ± 12.4

0.0850b

  1. aFisher’s exact test; b t-test assuming unequal variances (Satterthwaite method)
  2. Group A: eyes receiving the TE regimen for 2 years; Group B: eyes receiving the TE regimen in Year 1 and the PRN regimen in Year 2. PRN: pro re nata; SD: standard deviation; TE: treat-and-extend; VA: visual acuity
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us